Synonyms: Probalan®
probenecid is an approved drug (FDA (1951))
Compound class:
Synthetic organic
Comment: Probenecid is considered to be the prototypical uricosuric agent.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖View more information in the IUPHAR Pharmacology Education Project: probenecid |
|
Bioactivity Comments |
Competitive inhibition by probenecid has been demonstrated at OAT1, OAT2, OAT3, OAT4, OAT5 [5,8,11,14], and URAT1 [13]. Furthermore, inhibition by probenecid has also been demonstrated at MRP1, MRP2, MRP3, MRP4 and MRP5 [1,4,6,9,12]. |
Transporters Moving this Compound Across a Lipid Membrane | ||||||||
|
Selectivity at GPCRs | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Selectivity at ion channels | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|
Selectivity at transporters | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|